[{"NetIncomeLoss_1_Q3_USD":-8085000.0,"DilutiveSecurities_3_Q3_USD":0.0,"DilutiveSecurities_1_Q3_USD":0.0,"RestructuringCharges_1_Q3_USD":-952000.0,"RestructuringCharges_3_Q3_USD":-849000.0,"AssetsCurrent_0_Q3_USD":135591000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":348000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":5000.0,"ContractWithCustomerLiability_0_Q3_USD":0.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":69000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":97034000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":97034000.0,"Depreciation_1_Q3_USD":34000.0,"Depreciation_3_Q3_USD":78000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-318000.0,"PaymentsForRestructuring_3_Q3_USD":2785000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":28700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3_Q3_shares":4957800.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":2.79,"OtherNoncashExpense_3_Q3_USD":null,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":8129823.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1384000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":360000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":419000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":0.39,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":9530832.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":23158593.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":2591000.0,"RepaymentsOfBankDebt_3_Q3_USD":null,"Assets_0_Q3_USD":154710000.0,"CommonStockSharesIssued_0_Q3_shares":109468945.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":336000.0,"NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_3_Q3_USD":213000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":286000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":402000.0,"ShareBasedCompensation_3_Q3_USD":3871000.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"InterestPaidNet_3_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":3724000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":133214000.0,"RevenueRemainingPerformanceObligation_0_Q3_USD":18000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-11000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-13000.0,"CommonStockValue_0_Q3_USD":11000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":26000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":205000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":810000.0,"AccountsReceivableNetCurrent_0_Q3_USD":250000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":6386000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":3150000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":2.27,"ResearchAndDevelopmentExpense_1_Q3_USD":4616000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":11272000.0,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":1244974.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":265000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":1732000.0,"ContractWithCustomerAssetNetCurrent_0_Q3_USD":0.0,"AmortizationOfIntangibleAssets_3_Q3_USD":1299000.0,"OtherAssetsNoncurrent_0_Q3_USD":72000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":1731000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":107718578.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":81121045.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4190000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":10076000.0,"DepreciationAndAmortization_3_Q3_USD":1846000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":433000.0,"MoneyMarketFundsAtCarryingValue_0_Q3_USD":100002000.0,"OperatingLeaseLiability_0_Q3_USD":2731000.0,"IncreaseDecreaseInOtherAccruedLiabilities_3_Q3_USD":-1511000.0,"Liabilities_0_Q3_USD":23032000.0,"Cash_0_Q3_USD":33436000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":266687000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":1032000.0,"ShortTermLeaseCommitmentAmount_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OperatingIncomeLoss_3_Q3_USD":-16809000.0,"OperatingIncomeLoss_1_Q3_USD":-7589000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":1554328.0,"InterestExpense_1_Q3_USD":null,"InterestExpense_3_Q3_USD":null,"NonoperatingIncomeExpense_1_Q3_USD":-470000.0,"NonoperatingIncomeExpense_3_Q3_USD":-1345000.0,"AccountsPayableCurrent_0_Q3_USD":1871000.0,"LiabilitiesCurrent_0_Q3_USD":10302000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1719000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":133438000.0,"ProceedsFromWarrantExercises_3_Q3_USD":25951000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3_Q3_shares":6400000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":915000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":3871000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":3000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":10.57,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3_Q3_shares":57751.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":537000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-12984000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":1732000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":1903000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":529000.0,"NetIncomeLoss_3_Q3_USD":-18359000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":662000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"OperatingLeasePayments_1_Q3_USD":243000.0,"OperatingLeasePayments_3_Q3_USD":717000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":15794000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":305179.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":402000.0,"ShortTermLeaseCost_1_Q3_USD":4000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q3_USD":2966000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_3_Q3_USD":2966000.0,"SubleaseIncome_1_Q3_USD":54000.0,"SubleaseIncome_3_Q3_USD":163000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":10800000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.1034,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":15794000.0,"ShortTermLeaseCost_3_Q3_USD":10000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":2539452.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":1732000.0,"CommonStockSharesOutstanding_0_Q3_shares":109468945.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":1199000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":85992.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":5400000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":1132000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":154710000.0,"OperatingLeaseCost_1_Q3_USD":235000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1699000.0,"OperatingLeaseCost_3_Q3_USD":636000.0,"PreferredStockValue_0_Q3_USD":null,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":22180000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":2.1,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":1600000.0,"RestructuringReserve_0_Q3_USD":14000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-8059000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-18154000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":1.32,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":433000.0,"OperatingExpenses_3_Q3_USD":20499000.0,"OperatingExpenses_1_Q3_USD":7854000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-3369000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":119912000.0,"LeaseCost_1_Q3_USD":214000.0,"LeaseCost_3_Q3_USD":536000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-135020000.0,"VariableLeaseCost_1_Q3_USD":29000.0,"VariableLeaseCost_3_Q3_USD":53000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":6320530.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":265000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":3690000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":321000.0,"StockholdersEquity_0_Q3_USD":131678000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":null,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.08,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.23,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1022000.0,"RestructuringAndRelatedCostCostIncurredToDate1_0_Q3_USD":4071000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":677000.0,"Ticker":"VXRT","CIK":"72444","name":"VAXART, INC.","OfficialName":"Vaxart Inc Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"564888665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]